Target Gene Table ▼
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS42001004EBVENSG00000140009.19protein_codingESR2NoNo2100Q92731
TVIS10045761HBVENSG00000140009.19protein_codingESR2NoNo2100Q92731
TVIS10045762HBVENSG00000140009.19protein_codingESR2NoNo2100Q92731
TVIS30036598HIVENSG00000140009.19protein_codingESR2NoNo2100Q92731
TVIS30036599HIVENSG00000140009.19protein_codingESR2NoNo2100Q92731
TVIS30036600HIVENSG00000140009.19protein_codingESR2NoNo2100Q92731
TVIS30036601HIVENSG00000140009.19protein_codingESR2NoNo2100Q92731
TVIS20017167HPVENSG00000140009.19protein_codingESR2NoNo2100Q92731
TVIS20051518HPVENSG00000140009.19protein_codingESR2NoNo2100Q92731
TVIS20034451HPVENSG00000140009.19protein_codingESR2NoNo2100Q92731
TCGA Plot Options ▼
Drug Information ▼
GeneESR2
DrugBank IDDB13956
Drug NameEstradiol valerate
Target IDBE0000792
UniProt IDQ92731
Regulation Typeagonist
PubMed IDs17464340; 2011412
CitationsVijayanathan V, Greenfield NJ, Thomas TJ, Ivanova MM, Tyulmenkov VV, Klinge CM, Gallo MA, Thomas T: Effects of estradiol and 4-hydroxytamoxifen on the conformation, thermal stability, and DNA recognition of estrogen receptor beta. Biochem Cell Biol. 2007 Feb;85(1):1-10.@@Sasson S: Equilibrium binding analysis of estrogen agonists and antagonists: relation to the activation of the estrogen receptor. Pathol Biol (Paris). 1991 Jan;39(1):59-69.
GroupsApproved; Investigational; Vet_approved
Direct ClassificationSteroid esters
SMILES[H][C@@]12CC[C@H](OC(=O)CCCC)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
Pathways
PharmGKB
ChEMBLCHEMBL1511